There is limited information available specifically stating that human chorionic gonadotropin (HCG) is not helpful before microdissection testicular sperm extraction (microTESE).
HCG is a hormone that mimics the action of luteinizing hormone (LH) in the body. It is sometimes used in fertility treatments to stimulate the testes to produce testosterone and improve sperm production. However, its effectiveness in the context of microTESE remains a topic of debate and ongoing research.
Some studies suggest that the use of HCG before microTESE may not significantly improve the outcomes of the procedure. For example, a study published in the Journal of Urology in 2010 found that HCG administration did not significantly increase sperm retrieval rates during microTESE in men with nonobstructive azoospermia.
Another study published in Fertility and Sterility in 2015 also reported no significant improvement in sperm retrieval rates with the use of HCG prior to microTESE in men with nonobstructive azoospermia.
However, it’s important to note that the available research on this specific topic is limited, and there may be conflicting findings. Each case is unique, and the decision to use HCG or any other medication before microTESE should be made in consultation with a qualified healthcare professional who can assess individual circumstances and determine the most appropriate treatment plan.
It is recommended to discuss the potential benefits and risks of using HCG before microTESE with a fertility specialist or urologist who can provide personalized advice based on the specific situation and medical history.